Chung Ang University Industry Academic Cooperation

Hanwha Chemical Corporation

Chung-ang Univ Industry-academic Coop. Foundation

Won Yong Kim

Woo Jin Choi

Jong Hwa Kim

In Sik Chung

Wan Jae Myeong

Eung Gyu Kim

Ki Young Kim

Hyo Suk Kim

Ki Taeg Jung

Jang Won Yoon

Joo Hyoung Park

Dong-Hwa Shon

Kanjanasuntree Rungravee

Joung Woo Han

Jeong Hwan Chun

Qi Zhang

Young Jin Cho

Maytiya Konkit

Sung Lim Cho

Sang Gue Park

In-Hyuk Baek

Van Thai Than

Jong-Bum Kim

Hee Kuk Park

The present invention relates to astrain having preventive and reductive effects on fatty liver or metabolic syndrome. More particularly, the present invention relates to a composition at least one selected from the group consisting of the strain, a culture containing the strain, and a fermented material of the strain as an active ingredient for preventing, alleviating, and treating fatty liver or metabolic syndrome.

Composition comprisingfor prevention or treatment of fatty liver or metabolic syndrome

The present invention relates to a novelCAU Y1706 and a composition using same, and more specifically, to aCAU Y1706 (Accession No.: KCTC13794BP) strain, and a pharmaceutical composition, a food composition, a cosmetic composition, and a probiotic composition for preventing or treating inflammatory diseases, comprising the strain or a culture thereof as an active ingredient.

CAU Y1706 and composition using same

The present invention relates to a catalyst for hydrogenation of an aromatic compound, which is capable of greatly reducing the inactivation of a catalyst by using a support including a magnesium-based spinel structure, and a preparation method therefor.

Catalyst for hydrogenation of aromatic compound and preparation method therefor

The composition according to the present invention, which comprisesas an active ingredient, has excellent effects of preventing or treating inflammatory diseases, inhibiting the secretion of nitric oxide and prostaglandin E, which are major inflammatory factors, and inhibiting the secretion of &#x3b2;-hexosaminidase and histamine, which are major factors related to allergies, and also significantly suppressing the production of skin disease-related cytokines and chemokines. Such effects are at the same level as those of conventional skin disease therapeutic agents (tacrolimus), and thus the composition can be used as a preventive or therapeutic agent against inflammatory diseases. In addition, the composition according to the present invention exhibits an antibacterial activity against, which is a microorganism inducing a secondary infection of atopic dermatitis and the like, and thus can be used in preventing or treating a bacterial infection.

Pharmaceutical composition for preventing or treating inflammatory diseases, containingas active ingredient

A food composition for alleviating hangovers, the food composition contains, as an active ingredient, at least one strain selected from the group consisting ofsubsp.subsp., and, or a culture liquid thereof culture medium, wherein functional cream cheese is prepared using five species ofstrains above having the ability to decompose ethanol and acetaldehyde.

[object Object]

The present invention relates to an antimicrobial composition derived from a natural substance. Since the composition effectively suppresses, an organism that has been newly identified as causing dandruff, the present invention can effectively prevent and/or treat seborrhoeic dermatitis and dandruff. Also, since the antimicrobial composition of the present invention includes a natural substance as an active ingredient, little consumer aversion will result. Also, it is expected that the antimicrobial composition of the present invention can be used for developing an antidandruff agent having a reduced content of materials which are typically used as antidandruff agents and the safety of which is questionable.

Disclosed are a construct for expressing a rotavirus antigen complex loaded with a heterologous virus epitope, a vaccine composition containing the rotavirus antigen complex, a virus-like particle of rotavirus containing the rotavirus antigen complex, and a vaccine composition containing the virus-like particle of rotavirus. According to the present disclosure, an antigen complex containing a rotavirus antigen as well as a heterologous virus epitope and a virus-like particle of rotavirus containing the antigen complex can be produced in large scale at low cost. Thus, the present disclosure may be applied for research and development of novel complex vaccines for rotavirus and heterologous virus.

Method for preparing recombinant antigen complex using rotavirus nanoparticle

Growing community of inventors

Seoul, South Korea

Won Yong Kim